In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Venture Capital Off To Good Start After Record 2015; Tarveda Raises $38m

This article was originally published in Scrip

Executive Summary

US biotechnology companies raised a record-breaking $7.4bn in venture capital in 2015, and based on VC fundraising so far in January – including a $38m Series C round for Tarveda Therapeutics Inc. – 2016 looks like it may keep pace with last year.

Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

SC064316

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel